IV Versus IM Administration of Oxytocin for Postpartum Bleeding

• Status: Completed
• Trial end date: 2017-10-01
• Target enrollment: 0
• Participant gender: Female

Summary

This double-blind, randomized controlled trial will evaluate the effect of the route of administration of 10 IU of oxytocin on the average blood loss postpartum. Participants will be randomized to receive 10 IU of oxytocin by IV infusion or 10 IU of oxytocin by injection IM

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Gynuity Health Projects
• Collaborator: Centro Rosarino de Estudios Perinatales (CREP)
• Treatments: Oxytocin

Criteria

Inclusion Criteria:

• She is present to give birth to a live fetus

• Vaginal delivery

• Willing to participate in the study

• Able to give informed consent

Exclusion Criteria:

• Scheduled for a cesarean

• Reject the placement of an IV during labor (for intravenous infusion)

• Cannot give informed consent for any reason

• Not willing and / or cannot answer questions about background